Prem Watsa’s Fairfax Financial has added 1.2 million Under Armour shares, lifting his indirect stake to over 44 million. Disciplined value positioning in a recovery story with a streak of consecutive earnings beats but unresolved execution risk.
Prem Watsa, the Canadian deep-value investor who leads Fairfax Financial Holdings, has accumulated 1,178,344 shares of Under Armour through three open-market transactions, filing a Form 4 with the U.S. Securities and Exchange Commission (SEC). The purchase brings his total indirect stake to more than 44 million shares held through Fairfax subsidiaries. It is a modest add in absolute dollar terms. The framing, however, is more interesting than the size.
What the filing actually shows, and what it doesn’t
This last transaction does not reflect any shift in overall ownership structure. Watsa, sho is often compared in investment circles to Warren Buffett for his discipline in distressed value situations, appears to be treating Under Armour as a recovery bet. That is not activist accumulation. It reads as patient capital averaging into a thesis. And the thesis is: Under Armour may be succeed in its turnaround.
The turnaround thesis: real logic, uneven execution
Under Armour’s path over the past three years has been a controlled retreat from volume toward margin. The company has reduced its stock-keeping unit (SKU) count, pulled back from off-price and promotional channels, and brought in leadership aligned with brand elevation over revenue growth. That strategic direction is broadly correct for a brand that had over-distributed itself into discount retail. Execution, however, has been inconsistent, and the stock has kept declining.
Q4 fiscal 2026 revenue came in at $1.17 billion, narrowly beating analyst consensus. The underlying picture remains mixed. North American revenue declined 7 percent year-on-year in that quarter, while international regions absorbed the pressure, with EMEA (Europe, Middle East and Africa) up 7.1 percent, Asia Pacific up 12.7 percent and Latin America up 22.4 percent. The full fiscal year produced a net loss of $495.6 million.
Management is guiding for fiscal 2027 to be the first year of positive adjusted earnings per share in the current restructuring cycle. Yet Wall Street is cautious: five Buy ratings against 18 Holds and three Sells. This is wait-and-see, not momentum.
Fairfax’s reputation for disciplined contrarian investing gives this accumulation more interpretive weight than a routine institutional rebalancing. Watsa is not buying because the turnaround is proven. Watsa is buying because, at this price, the downside looks bounded and the stock is priced for continued disappointment. Under Armour still has to show that its product reset, marketing pivot and international growth can outrun persistent North American softness. Watsa’s incremental add suggests that trade is not yet priced in. Whether it pays off depends on execution the brand has not yet consistently delivered.
